摘要
目的:分析上海中医药大学附属市中医医院(以下简称"本院")含毒性中药饮片中成药的使用情况,为医疗机构合理管理含毒性中药饮片中成药提供参考。方法:统计本院含毒性中药饮片中成药的品种,对其说明书、所含毒性饮片的类型、毒性大小以及各科室使用情况等进行系统分析。结果:本院对于含毒性中药饮片中成药的临床应用仍存在不合理用药现象。结论:部分含毒性中药饮片中成药说明书存在对所含毒性中药饮片的使用禁忌及注意事项等表述不明确的情况,医疗机构必须自我加强对含毒性中药饮片中成药的管理及其合理使用,减少临床不良反应的发生率,保障用药安全。
Objective:To analyze the use of Chinese patent medicine containing toxic herbs in the Department of Pharmacy,Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine(hereinafter referred to as"our hospital"),and provide references for the rational management of Chinese patent medicines containing toxic herds in medical institutions.Methods:Statistics of the varieties of Chinese patent medicines containing toxic herbs in our hospital,the manual,the types of toxic herbs,the toxicity and the use of the materials were analyzed.Results:There were still irrational drug use phenomena in clinical application of Chinese patent medicines containing toxic Chinese traditional medicine decoction pieces in our hospital.Conclusion:The instructions of some Chinese patent medicines containing toxic TCM decoction pieces are not clear about the contraindication and precautions,etc.Medical institutions must strengthen the management and rational use of Chinese patent medicines containing toxic TCM decoction pieces,reduce the incidence rate of adverse clinical reactions,and ensure the safety of drug use.
作者
朱海青
薛亚
张立超
Zhu Haiqing;Xue Ya;Zhang Lichao(Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai,200071,China)
出处
《中国药事》
CAS
2021年第2期198-205,共8页
Chinese Pharmaceutical Affairs
基金
全国中药特色技术传承人才培训项目(编号国中医药人教函[2018]204号)。
关键词
毒性饮片
中成药
处方审核
管理
toxic medicine
Chinese patent medicine
prescription review
management
